DE LUCA, GIAMPIERO,YTHIER, ARNAUD,MUNAFO, ALAIN,LOPEZ-BRESNAHAN, MARIA
申请号:
AT05823474
公开号:
AT547106T
申请日:
2005.12.20
申请国别(地区):
AT
年份:
2012
代理人:
摘要:
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.